A detailed history of Geode Capital Management, LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,866,186 shares of SGMO stock, worth $3.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,866,186
Previous 3,363,791 44.52%
Holding current value
$3.81 Million
Previous $2.25 Million 70.22%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$0.36 - $0.65 $539,137 - $973,443
-1,497,605 Reduced 44.52%
1,866,186 $671,000
Q1 2024

May 13, 2024

BUY
$0.42 - $1.38 $66,142 - $217,323
157,481 Added 4.91%
3,363,791 $2.25 Million
Q4 2023

Feb 13, 2024

BUY
$0.3 - $0.63 $62,515 - $131,281
208,384 Added 6.95%
3,206,310 $1.73 Million
Q3 2023

Nov 13, 2023

BUY
$0.58 - $1.47 $82,460 - $208,995
142,174 Added 4.98%
2,997,926 $1.8 Million
Q2 2023

Aug 11, 2023

BUY
$1.11 - $1.74 $295,727 - $463,572
266,421 Added 10.29%
2,855,752 $3.71 Million
Q1 2023

May 15, 2023

BUY
$1.66 - $3.67 $156,803 - $346,668
94,460 Added 3.79%
2,589,331 $4.56 Million
Q4 2022

Feb 13, 2023

BUY
$2.77 - $5.07 $311,447 - $570,050
112,436 Added 4.72%
2,494,871 $7.83 Million
Q3 2022

Nov 14, 2022

BUY
$4.27 - $6.39 $911,311 - $1.36 Million
213,422 Added 9.84%
2,382,435 $11.7 Million
Q2 2022

Aug 12, 2022

BUY
$3.28 - $6.21 $251,385 - $475,946
76,642 Added 3.66%
2,169,013 $8.98 Million
Q1 2022

May 13, 2022

SELL
$5.23 - $7.82 $715,526 - $1.07 Million
-136,812 Reduced 6.14%
2,092,371 $12.2 Million
Q4 2021

Feb 11, 2022

BUY
$7.29 - $10.97 $246,693 - $371,224
33,840 Added 1.54%
2,229,183 $16.7 Million
Q3 2021

Nov 12, 2021

BUY
$9.01 - $12.01 $1.21 Million - $1.62 Million
134,807 Added 6.54%
2,195,343 $19.8 Million
Q2 2021

Aug 13, 2021

BUY
$10.17 - $12.64 $819,457 - $1.02 Million
80,576 Added 4.07%
2,060,536 $24.7 Million
Q1 2021

May 12, 2021

BUY
$10.88 - $17.05 $1.8 Million - $2.82 Million
165,123 Added 9.1%
1,979,960 $24.8 Million
Q4 2020

Feb 12, 2021

BUY
$9.23 - $18.18 $516,907 - $1.02 Million
56,003 Added 3.18%
1,814,837 $28.3 Million
Q3 2020

Nov 13, 2020

SELL
$9.38 - $12.48 $128,205 - $170,576
-13,668 Reduced 0.77%
1,758,834 $16.6 Million
Q2 2020

Aug 13, 2020

BUY
$6.21 - $11.83 $518,392 - $987,532
83,477 Added 4.94%
1,772,502 $15.9 Million
Q1 2020

May 14, 2020

BUY
$5.05 - $8.85 $527,502 - $924,435
104,456 Added 6.59%
1,689,025 $10.8 Million
Q4 2019

Feb 13, 2020

BUY
$8.03 - $11.7 $414,356 - $603,731
51,601 Added 3.37%
1,584,569 $13.3 Million
Q3 2019

Nov 12, 2019

BUY
$9.05 - $12.22 $423,702 - $572,115
46,818 Added 3.15%
1,532,968 $13.9 Million
Q2 2019

Aug 14, 2019

BUY
$8.75 - $13.03 $2.04 Million - $3.04 Million
233,677 Added 18.66%
1,486,150 $16 Million
Q1 2019

May 14, 2019

BUY
$7.72 - $12.81 $950,393 - $1.58 Million
123,108 Added 10.9%
1,252,473 $11.9 Million
Q4 2018

Feb 13, 2019

BUY
$9.51 - $16.6 $149,782 - $261,450
15,750 Added 1.41%
1,129,365 $13 Million
Q3 2018

Nov 13, 2018

BUY
$13.05 - $19.05 $418,213 - $610,495
32,047 Added 2.96%
1,113,615 $18.9 Million
Q2 2018

Aug 14, 2018

BUY
$13.9 - $19.8 $3.39 Million - $4.82 Million
243,573 Added 29.07%
1,081,568 $15.4 Million
Q1 2018

May 15, 2018

SELL
$16.7 - $26.35 $35,220 - $55,572
-2,109 Reduced 0.25%
837,995 $15.9 Million
Q4 2017

Feb 13, 2018

BUY
$11.6 - $17.35 $221,409 - $331,159
19,087 Added 2.32%
840,104 $13.8 Million
Q3 2017

Nov 14, 2017

BUY
$8.4 - $15.0 $784,576 - $1.4 Million
93,402 Added 12.84%
821,017 $12.3 Million
Q2 2017

Aug 14, 2017

BUY
N/A
727,615
727,615 $6.4 Million

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $319M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.